Canada markets open in 8 hours 1 minute

ImmuPharma PLC (25I.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.0215-0.0020 (-8.51%)
At close: 03:44PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
69.959
0
118.35
126.667
77.925
Operating Expenses
Research Development
1,808
2,023
3,650
2,373
2,665
Selling General and Administrative
703.248
846.571
1,011
1,765
1,831
Total Operating Expenses
2,728
3,029
5,278
5,716
6,360
Operating Income or Loss
-2,658
-3,029
-5,160
-5,589
-6,282
Interest Expense
-173.698
2.036
124.063
230.828
4.045
Income Before Tax
-3,764
-4,456
-8,941
-7,246
-6,744
Income Tax Expense
-772.569
-648.902
-766.814
-386.248
-620.774
Income from Continuing Operations
-2,991
-3,807
-8,174
-6,860
-6,124
Net Income
-2,991
-3,807
-8,174
-6,860
-6,124
Net Income available to common shareholders
-2,991
-3,807
-8,174
-6,860
-6,124
Basic EPS
-0.01
-0.01
-0.03
-0.03
-0.04
Diluted EPS
-0.01
-0.01
-0.03
-0.03
-0.04
Basic Average Shares
327,122
302,913
251,164
200,176
153,452
Diluted Average Shares
327,122
302,913
251,164
200,176
153,452